CTSI’s Research Team Building Consultation Service

Sponsor:

NYU Langone Medical Center’s Clinical and Translation Science Institute

Deadline:

Rolling, but space is limited.

Summary:

The Research Team Building Consultation Service, funded through NYULMC’s CTSI mentoring program, was designed to help investigators at various stages (post docs through more senior investigators) build or enhance their team to improve research productivity while providing mentoring and training to the next generation of scholars, particularly those underrepresented in science. We help faculty/post docs build labs, design teams, and recruit over a 12-month period.

Eligibility:

No additional eligibility restrictions.

Available Funding:

Not applicable. The service will provide 15 hours of individual consultation for each investigator.

Link to Full RFP:

CTSI July 2017 Newsletter

Heineken Prizes 2018

Sponsor:

Dr H.P. Heineken Foundation and the Alfred Heineken Fondsen Foundation. The selection of the prizes is entrusted by the Royal Netherlands Academy of Arts and Sciences.

Deadline:

October 15, 2017

Summary:

The Heineken Prizes are intended explicitly for scientists and scholars who are currently active in their field and whose research still holds considerable promise for future innovative discoveries. International juries will select the winners.

Eligibility:

Prizes are available in the following fields:

Available Funding:

$200,000

Link to Full RFP:

http://www.knaw.nl/en/awards/awards/heinekenprizes/heinekenprijs-voor-de-milieuwetenschappen

MSK Lymphoma SPORE 2017-2018 Career Enhancement Program (CEP) Awards

Sponsor:
Hosted at Memorial Sloan Kettering Cancer Center – Funded by the National Institutes of Health

Deadline:

July 28, 2017

Summary:

The aim of this RFA is to identify, train and/or develop talented individuals to become successful translational investigators in the field of lymphoma. The program will support 1 or 2 individuals per year for up to two years per awardee, based on competitive renewal. Awardees will be integrated into the SPORE in order to monitor their progress and ensure successful outcome of their research projects, and will be prepared to obtain independent peer-reviewed funding.

Eligibility:

Investigators at Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medical Center, Columbia University, Mount Sinai Hospital, and NYU, are eligible.
Funds from this program may be used to support junior faculty or established investigators who wish to enhance or refocus their careers on translational research. Eligible candidates will include individuals with the following qualifications:
a) M.D. (or D.O), PhD, or MD/PhD degree. This program is not a training program and does not support pre- or post-doctoral fellows, either pre-clinical or clinical. However, advanced post-doctoral or clinical fellows who provide a letter from an institution stating that the candidate will be joining its faculty within the year are eligible for this program.
b) Commitment to a career path in translational lymphoma research. Candidates must have demonstrated a strong aptitude for and interest in biomedical research, as evidenced by experience in the laboratory or other relevant research.
c) Exceptional clinical candidates that do not currently have an active laboratory program may also apply, provided they have a strong scientific/laboratory background, and are working with a laboratory mentor who can provide them with the necessary guidance and resources to develop a hypothesis that can be tested in the clinical setting
d) Investigators supported by NCI career development awards (K series) may also be eligible for support through this program. Investigators with previous R01 or equivalent level of funding related to lymphoma translational research are not eligible

Anticipated Funding Amount:

The program will support 1 or 2 individuals per year for up to two years per awardee, based on competitive renewal. The maximum award will be $50,000 for one year. Applicants will be funded for a maximum of two years with funding for the second year contingent on documented significant progress during the first year of funding, and peer review evaluations.

PROPOSAL PROCESS:

Proposals cannot be currently funded by an extramural agency or foundation. The budget is limited to $50K/year (direct costs. No indirect costs). Proposals must be submitted to Felicia Reid reidf@mskcc.org by July 24th, 2017.

REQUIRED INFORMATION:

Research proposals must be no longer than 5 pages (excluding budget) and should follow the format for an R01 grant application; the length of the final proposal are limited to 6 pages. The proposals will require the following standard NIH format:
Format: Applications must be in 11-point Arial. Margins must be at least 0.50 inches wide on all sides of each page.
1) Face Page (including Title, Name of Applicant, and Names of Key Collaborators)
2) Abstract (250 words max)
3) Research Plan (5-page limit). Include the following content: Specific Aims, Preliminary Studies, and Research Strategy (a. Significance, b. Innovation, c. Approach)
4) Research environment (1 page)
5) Include up to 6 Literature Citations
6) Human Subjects or Vertebrate Animals. (Please follow the NIH guidelines)
7) NIH Biosketch for all key personnel (5 pages each in NIH-specified format)
8) Budget and Budget Justification. Include a detailed NIH-format Budget for one year totaling $50,000 direct costs. The application must include a detailed budget for the initial year, a summary budget, and a budget justification.
9) The application should include a statement of long-term career goals, letter of support from the mentor with the Mentor’s CV, and 3 letters of recommendation.
REVIEW CRITERIA:
Applications will be reviewed and scored by the CEP Committee, which is composed of a diverse pool of experienced individuals with laboratory and clinical expertise. The CEP Co-Directors will assign two reviewers from the CEP Committee (one primary and one secondary reviewer) for each proposal. The initial selection will be based on the following criteria:
1. Scientific merit of the proposed project
2. Innovation
3. Approach
4. Qualifications of the investigator
5. Qualifications of the mentor
6. Research environment
IRB approval (or waiver) will be required before funding if the study involves human subjects.
SCIENTIFIC REVIEW COMMITTEE:
The CEP Co-Directors will assign two reviewers from the CEP Committee (one primary and one secondary reviewer) for each proposal.
FUNDING CYCLES:
Awards will begin in August 2017
Authors must cite the MSK Lymphoma SPORE (P50 CA192937) in the funding acknowledgements when submitting a manuscript based on research supported, in whole or in part, by this SPORE-Career Enhancement Program.
Written progress and final reports will be required at the end of funding period. Any questions regarding this solicitation should be directed to Felicia Reid reidf@mskcc.org or to the CEP directors; Dr. Riccardo Dalla Favera rd10@cumc.columbia.edu or Dr. Andrew Zelenetz Zelenetz a-zelenetz@ski.mskcc.org.
KEY DATES:
• Applications are due on July 24th, 2017
• Award Announcements by August 18th, 2017
• Award Start Date: August 30th, 2017
SUBMISSION INFORMATION:
Proposals must be submitted electronically to Felicia Reid reidf@mskcc.org. Proposals must be submitted as a compiled PDF document.
ADDITIONAL BUDGET INFORMATION:
Up to $50K direct costs for one year, may be renewable for an additional year based on review
Expenditures allowed
1 Research supplies and animal maintenance.
2 Technical assistance.
3 Publication costs, including reprints.
4 Data analysis.
5 Special fees (pathology, photography, etc.).
6 Stipends for graduate students and postdoctoral fellows.
The following expenditures will not be considered:
1 Secretary or administrative personnel.
2 Office equipment or supplies.
3 Laboratory equipment or computers.
4 Tuition.
5 Foreign travel.
6 Honoraria and travel expenditures.
7 Recruitment.
8 Patient care charges (requires justification if a clinical trial is proposed).
9 Non-medical or personal services to patients

 

MSK Lymphoma SPORE 2017-2018 Developmental Research Program (DRP) Awards

Sponsor:
Hosted at Memorial Sloan Kettering Cancer Center – Funded by the National Institutes of Health

Deadline:

July 28, 2017

Summary:

This RFA is designed to support young investigators as well as established investigators focusing on basic, translational, or clinical research of lymphoma. The primary objective of this DRP Award is to support pilot projects that explore innovative ideas in basic and translational research in lymphoma. Potential topics of interest include, but are not limited to:
• Pathogenesis
• Experimental therapeutics, including mechanism based combinations, and biomarker driven treatment strategies
• Immunology and immunotherapies
• Circulating tumor DNA

Eligibility:

Investigators at Memorial Sloan Kettering Cancer Center, Rockefeller University, Weill Cornell Medical Center, Columbia University, Mount Sinai Hospital, and NYU, are eligible.
Applicants must hold academic rank of Instructor, Assistant Professor, or higher.
Applicants must possess an MD, DO or a PhD degree in a relevant area of research. The pilot projects may be collaborative among scientists within one or more SPOREs, or with scientists outside the SPORE community including the international scientific community. High risk/high payoff pilot projects are especially encouraged. These pilot projects do not need to reach a human endpoint during the project period as do full projects, including the Developmental Research Program. Letters of collaboration (if if applicable)

Proposals cannot be currently funded by an extramural agency or foundation. The budget is limited to $50K/year (direct costs. No indirect costs).

Anticipated Funding Amount:

Each year, 3-4 applications will be funded. The maximum award will be $50,000 for one year. Applicants will be funded for a maximum of two years with funding for the second year contingent on documented significant progress during the first year of funding, and peer review evaluations.

PROPOSAL PROCESS:

Proposals cannot be currently funded by an extramural agency or foundation. The budget is limited to $50K/year (direct costs. No indirect costs). Proposals must be submitted to Felicia Reid reidf@mskcc.org by July 24th, 2017.

REQUIRED INFORMATION:
Research proposals must be no longer than 5 pages (excluding budget) and should follow the format for an R01 grant application; the length of the final proposal are limited to 6 pages. The proposals will require the following standard NIH format:
Format: Applications must be in 11-point Arial. Margins must be at least 0.50 inches wide on all sides of each page.
MSK Lymphoma SPORE
2017-2018 Developmental Research Program (DRP) Awards
1) Face Page (including Title, Name of Applicant, and Names of Key Collaborators)
2) Abstract (250 words max)
3) Research Plan (5-page limit). Include the following content: Specific Aims, Preliminary Studies, and Research Strategy (a. Significance, b. Innovation, c. Approach)
6) Research environment (1 page)
7) Include up to 6 Literature Citations
8) Human Subjects or Vertebrate Animals. (Please follow the NIH guidelines)
9) NIH Biosketch for all key personnel (5 pages each in NIH-specified format)
10) Budget and Budget Justification. Include a detailed NIH-format Budget for one year totaling $50,000 direct costs. The application must include a detailed budget for the initial year, a summary budget, and a budget justification.
REVIEW CRITERIA:
All proposals will be reviewed by the scientific review committee and ad hoc reviewers, according to the following criteria, as relevant:
1. Scientific merit of the proposed project
2. Innovation
3. Approach
4. Qualifications of the investigator
5. Research environment
IRB approval (or waiver) will be required before funding if the study involves human subjects.
SCIENTIFIC REVIEW COMMITTEE:
The DRP Review Committee will include 3 ad hoc members of the SPORE Internal Advisory Board Committee, and 3 ad hoc members of the SPORE External Advisory Board Committee, and 3 additional external reviewers from other lymphoma SPORES
FUNDING CYCLES:
Awards will begin in August 2017
Authors must cite the MSK Lymphoma SPORE (P50 CA192937) in the funding acknowledgements when submitting a manuscript based on research supported, in whole or in part, by this SPORE-Developmental Research Program.
Written progress and final reports will be required at the end of funding period. Any questions regarding this solicitation should be directed to Felicia Reid reidf@mskcc.org or to the DRP directors; Dr. John Leonard jpleonar@med.cornell.edu or Dr. Anas Younes younesa@mskcc.org.
KEY DATES:
• Applications are due on July 24th, 2017
• Award Announcements by August 18th, 2017
• Award Start Date: August 30th, 2017

SUBMISSION INFORMATION:
Proposals must be submitted electronically to Felicia Reid reidf@mskcc.org. Proposals must be submitted as a compiled PDF document.
ADDITIONAL BUDGET INFORMATION: Up to $50K direct costs for one year, may be renewable for an additional year based on review
Expenditures allowed
1 Research supplies and animal maintenance.
2 Technical assistance.
3 Publication costs, including reprints.
4 Data analysis.
5 Special fees (pathology, photography, etc.).
6 Stipends for graduate students and postdoctoral fellows.
The following expenditures will not be considered:
1 Secretary or administrative personnel.
2 Office equipment or supplies.
3 Laboratory equipment or computers.
4 Tuition.
5 Foreign travel.
6 Honoraria and travel expenditures.
7 Recruitment.
8 Patient care charges (requires justification if a clinical trial is proposed).
9 Non-medical or personal services to patients.

Centers for Chemical Innovation – Phase I (CCI) (NSF 17-564)

Sponsor:

National Science Foundation

Deadline:

Preliminary Proposals: September 12, 2017

Full Proposals (by invitation only): March 06, 2018

Summary:

The Centers for Chemical Innovation (CCI) Program supports research centers focused on major, long-term fundamental chemical research challenges. CCIs are agile structures that respond rapidly to emerging opportunities, promote synergy, enhance collaborations, and engage in potentially transformative research. CCIs integrate research, innovation, education, broadening participation, and informal science communication.

The FY 2018 Phase I CCI competition is open to projects in all fields supported by the Division of Chemistry. Successful proposals will have a clear chemistry focus and the potential for transformative impact in chemistry. The Division of Chemistry particularly encourages CCI centers or projects within centers aligned with Data-Driven Discovery Science in Chemistry (D3SC). Such CCI projects would seek new chemical understanding through sharing, mining and repurposing of chemical datasets and through the use of state-of-the-art data analysis techniques. Additional context for D3SC and links to related documents can be found at NSF 17-036.

The research activities may build on pre-existing efforts, but new, collaborative results attributed to the CCI award are expected. The Phase I award will also develop broader impact activities in the four required areas (see below), including piloting and developing center-scale activities commensurate with a Phase II CCI. Center development includes the development of a strategic plan covering all aspects of a CCI (see full RFP).

CCIs are expected to integrate their research with activities that broaden the impact of their research. A Phase I team might pilot activities in these areas:

  • Innovation – translation or transfer of basic research results into economic or societal benefit. This element includes intellectual property protection and a proactive plan to either engage industry in technology transfer or to commercialize technology in other ways.
  • Higher Education and Professional Development – education and professional development for undergraduate and graduate students supported by the grant, including co-mentorship or other collaborative training and continued professional development and mentoring for postdoctoral research associates. This may also include education in various aspects of innovation (intellectual property, entrepreneurship, etc.) and other higher education activities (i.e., new course materials or curricula).
  • Broadening the participation of underrepresented groups – CCI goals for increasing engagement by underrepresented groups, plans for reaching those goals, and an evaluation strategy.
  • Informal science communication – plans for communicating the CCI research to public audiences and possible ways to evaluate the impact of these outreach efforts.

Eligibility:

Who May Serve as PI:

  • While these proposals will reflect the research of many investigators, only the name of the Principal Investigator (PI) should appear on the cover sheet. All other investigators are considered Faculty Associates (non-coPI senior personnel). An investigator may participate (as PI or Faculty Associate) in only one CCI preliminary proposal and one CCI full proposal (Phase I or Phase II) submitted to this competition. The PI must be affiliated with an eligible submitting organization.

Limit on Number of Proposals per PI or Co-PI: 1

  • An investigator may participate (as PI or Faculty Associate) in only one preliminary proposal and one full proposal (Phase I or Phase II) submitted in response to this solicitation. The PI must be affiliated with an eligible submitting organization.

The team of investigators for a Phase I proposal must include at least four senior researchers with complementary expertise. While there is no upper limit on the number of Phase I investigators, proposers are cautioned to avoid teams that are too large to collaborate effectively. The available resources should also be carefully considered in assembling the team. CCIs may partner with researchers from industry, national laboratories and international organizations. See detailed guidance below for non-U.S. or non-academic researchers.

Available Funding:

NSF anticipates making three new Phase I awards (up to $1,800,000 for 3 years) as standard or continuing grants.

Link to Full RFP:

https://www.nsf.gov/pubs/2017/nsf17564/nsf17564.htm?WT.mc_id=USNSF_25&WT.mc_ev=click#elig

ONR Young Investigator Program

Sponsor:

Office of Naval Research

Deadline:

September 15, 2017

Summary:

The Office of Naval Research (ONR) is interested in receiving proposals for its Young Investigator Program (YIP). ONR’s Young Investigator Program (YIP) seeks to identify and support academic scientists and engineers who are in their first or second full-time tenure-track or tenure-trackequivalent academic appointment, have begun their first appointment on or after 31 December 2012, and who show exceptional promise for doing creative research. The objectives of this program are to attract outstanding faculty members of Institutions of Higher Education (hereafter also called “universities”) to the Department of the Navy’s Science and Technology (S&T) research program, to support their research, and to encourage their teaching and research careers.

Proposals addressing research areas (as described in the ONR Science and Technology Department section of ONR’s website at www.onr.navy.mil) which are of interest to ONR program officers will be considered. Contact information for each division (a subgroup of an S&T Department) is also listed within the S&T section of the website.

Eligibility:

The Principal Investigator of a proposal must be a U.S. citizen, national, or permanent resident (on the date proposals are due), holding a first or second full-time tenure-track or tenure-track-equivalentfaculty position at that university, and has begun her/his first full-time appointment on or after 31 December 2012.

Available Funding:

Applicants may request up to $170,000 per year for three (3) years. (Additional funds for capital equipment which enhances the Young Investigator’s proposed research may be requested.)

Link to Full RFP:

https://www.grants.gov/custom/viewOppDetails.jsp?oppId=294449

Clinical Trial Award – FY17 Peer Reviewed Medical Research Program (PRMRP)

Sponsor:

United States Department of Defense

Deadline:

Pre-Application (required): July 20, 2017

Application (by invitation only): October 26, 2017

Summary:

All applications for PRMRP funding must specifically address at least 1 of the 48 Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  Please see RFP for Topic Areas.

The PRMRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on a disease or condition addressed in at least one of the Congressionally directed FY17 PRMRP Topic Areas. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proofof-concept trials (e.g., pilot, first in human, Phase 0) to demonstrate feasibility or inform the design of more advanced trials, through large-scale trials to determine efficacy in relevant patient populations. All studies must be responsive to the healthcare needs of the military Service members, Veterans, and/or beneficiaries; however, the use of military or Veteran populations is not required.

Eligibility:

  • PIs at or above the level of Assistant Professor (or equivalent) are eligible to submit applications.
  • Funding from this award mechanism must support a clinical trial. Proposed projects may range from small proof-of-concept trials through large-scale, definitive trials.
  • Relevance to the healthcare needs of military Service members, Veterans, and beneficiaries is a key feature of this award. Applications are required to include an explanation of how the proposed project has military relevance.
    • PIs are encouraged to integrate and/or align their research projects with DoD and/or VA research laboratories and programs. Collaboration with the DoD or VA is also encouraged.

Available Funding:

Funding limit not defined; requested funding must be appropriate for the scope of work proposed/Maximum period of performance is 4 years

Link to Full RFP:

http://cdmrp.army.mil/funding/pa/FY17-PRMRP-CTA.pdf

Discovery Award – FY17 Peer Reviewed Medical Research Program (PRMRP)

Sponsor:

United States Department of Defense

Deadline:

Pre-Application (required):  July 19, 2017

Application (by invitation only):  August 2, 2017

Summary:

All applications for PRMRP funding must specifically address at least 1 of the 48 Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  Please see RFP for Topic Areas.

The intent of the PRMRP Discovery Award is to support innovative, non-incremental, highrisk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications. Studies supported by this award are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a wellformulated, testable hypothesis based on a sound scientific rationale and study design.

The outcome of research supported by this award should be the generation of preliminary data that can be used as a foundation for future research projects to understand the mechanisms of initiation or progression and/or improving patient care for a disease or condition.

Eligibility:

  • Investigators at the level of postdoctoral fellow or clinical fellow (or equivalent) and above are eligible to submit applications.
  • Relevance to the healthcare needs of military Service members, Veterans, and beneficiaries is a key feature of this award. Applications are required to include an explanation of how the proposed project has military relevance.
    • PIs are encouraged to integrate and/or align their research projects with DoD and/or VA research laboratories and programs. Collaboration with the DoD or VA is also encouraged.

Available Funding:

Maximum of $200,000 for direct costs (plus indirect costs)/ Maximum period of performance is 18 months

Link to Full RFP:

http://cdmrp.army.mil/funding/pa/FY17-PRMRP-DA.pdf

Focused Program Award – FY17 Peer Reviewed Medical Research Program (PRMRP)

Sponsor:

United States Department of Defense

Deadline:

Pre-Application (required):  July 20, 2017

Application (by invitation only):  October 26, 2017

Summary:

All applications for PRMRP funding must specifically address at least 1 of the 48 Topic Areas as directed by Congress and must be directly relevant to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  Please see RFP for Topic Areas. The PRMRP Focused Program Award mechanism is intended to optimize research and accelerate the solution for a critical question.

  • Projects must support a synergistic, multidisciplinary research program of at least four distinct but complementary projects addressing an overarching goal.
  • Projects should work together to answer critical questions, resolve differing hypotheses, and translate laboratory findings to clinical applications.
  • Projects may range from exploratory/ hypothesis-developing through small-scale clinical trials that together will address the overarching goal/question.
  • Research team of highly qualified, multidisciplinary project leaders should be led by a PI with demonstrated success in directing large, focused projects.

Eligibility:

  • The PI must be an independent investigator at or above the level of Full Professor (or equivalent).
  • The PI is required to devote a minimum of 20% effort to this award.
  • Project leaders for each of the complementary and synergistic research projects must be at or above the level of Assistant Professor (or equivalent).
  • Relevance to the healthcare needs of military Service members, Veterans, and beneficiaries is a key feature of this award. Applications are required to include an explanation of how the proposed project has military relevance.
    • PIs are encouraged to integrate and/or align their research projects with DoD and/or VA research laboratories and programs. Collaboration with the DoD or VA is also encouraged.

Available Funding:

The anticipated total costs budgeted for the entire period of performance will not exceed $10M / maximum period of performance is 4 years.

Link to Full RFP:

http://cdmrp.army.mil/funding/pa/FY17-PRMRP-FPA.pdf

POST-DOCTORAL TRAINING SUPPORT PROGRAM IN CLINICAL AND TRANSLATIONAL RESEARCH (TL1)

Sponsor:

Clinical and Translational Science Institute (CTSI)

Deadline:

5PM on June 27, 2017

Summary:

The TL1 offers support, mentoring and training opportunities for late-stage pre-doctoral and early-stage post-doctoral scholars conducting research in the area of health care and/or translational medicine. The program provides stipends, training and mentoring while emphasizing the scholar’s success within their established research area. The fundamental goal of the program is to help and support scholars as they advance in their research careers, and to provide them with the knowledge and skills to eventually develop into successful, independent researchers. The program encourages productivity, collaborative research and career development.

Eligibility:

Late-stage pre-doctoral PhD students who have completed required coursework, as well as early stage post-doctoral research scholars (1-2 years after completion of pre-doctoral training) are eligible to apply. Post-doctoral scholars should be actively engaged in translationally-relevant research. Scholars from any unit or school in the University, or with appointments at CTSI-affiliated New York City Health + Hospitals institutions, are eligible to apply. Applicants must have the support of their research advisor/mentor.

Available Funding:

The TL1 program will provide up to two years of stipend and other support. Based on NIH requirements, the stipend for pre-doctoral candidates will be set at a maximum of $22,920 annually. For post-doctoral scholars, salary will be set at NIH post-graduate year levels (See NIH website: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-048.html). Additional funds will be available for educational courses and travel to meetings. Pre-doctoral scholars who graduate, or post-doctoral scholars who successfully compete for an NIH K or R award or equivalent, will be rotated off the program.

Link to Full RFP:

https://med.nyu.edu/ctsi/training-education/research-career-development/tl1